Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount |
---|---|---|---|---|---|---|
Anda | Teva Pharmaceutical Industries | pharmaceuticals | Controlled Substances Act violation | 2016 | WV-AG | $1,800,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | consumer protection violation | 2019 | WV-AG | $1,600,000 |
Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2004 | WV-AG | $850,000 |
Johnson and Johnson | Johnson & Johnson | pharmaceuticals | consumer protection violation | 2009 | WV-AG | $4,475,000 |
Sanofi-Aventis | Sanofi | pharmaceuticals | consumer protection violation | 2019 | WV-AG | $1,600,000 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2020 | WV-AG | $3,900,000 |
Amgen Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2008 | WI-AG | $2,000,000 |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | pharmaceuticals | False Claims Act and related | 2010 | WI-AG | $7,750,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | WI-AG | $2,000,000 |
Merck and Company, Inc. | Merck | pharmaceuticals | False Claims Act and related | 2011 | WI-AG | $4,250,000 |
Pharmacia Corporation | Pfizer | pharmaceuticals | False Claims Act and related | 2013 | WI-AG | $29,453,247 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | pharmaceuticals | kickbacks and bribery | 2006 | WI-AG | $798,000 |
InterMune Inc. | Roche | pharmaceuticals | Family and Medical Leave Act | 2014 | WHD | $59,085 |
Perrigo Company | Perrigo | pharmaceuticals | Family and Medical Leave Act | 2014 | WHD | $15,022 |
Schering Corporation | Merck | pharmaceuticals | Family and Medical Leave Act | 2006 | WHD | $6,000 |
ExecuPharm, Inc. | Parexel International | pharmaceuticals | Family and Medical Leave Act | 2017 | WHD | $5,900 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2019 | WA-AG | $9,900,000 |
Biogen Idec Inc. | Biogen | pharmaceuticals | consumer protection violation | 2007 | VT-AG | $10,000 |
Otsuka America Pharmaceutical, Inc. | Otsuka Pharmaceutical | pharmaceuticals | consumer protection violation | 2007 | VT-AG | $10,000 |
Pfizer | Pfizer | pharmaceuticals | consumer protection violation | 2022 | VT-AG | $34,564 |
Merck Sharp & Dohme Corp. | Merck | pharmaceuticals | environmental violation | 2020 | VA-ENV | $20,925 |
Merck Sharp & Dohme Corp. | Merck | pharmaceuticals | environmental violation | 2019 | VA-ENV | $17,290 |
Novartis Pharmaceuticals | Novartis | pharmaceuticals | kickbacks and bribery | 2015 | USAO | $390,000,000 |
Mallinckrodt LLC | Mallinckrodt | pharmaceuticals | False Claims Act and related | 2013 | USAO | $3,500,000 |
Janssen Pharmaceuticals, Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | USAO | $410,000,000 |
Novo Nordisk Inc. | Novo Holdings A/S | pharmaceuticals | False Claims Act and related | 2011 | USAO | $1,725,000 |
Synthes Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2010 | USAO | $669,800 |
Forest Pharmaceuticals Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2010 | USAO | $149,000,000 |
Ortho-McNeil Pharmaceutical LLC | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2010 | USAO | $6,140,000 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | Controlled Substances Act violation | 2008 | USAO | $511,000 |
Pharmacia & Upjohn Company Inc. | Pfizer | pharmaceuticals | kickbacks and bribery | 2007 | USAO | $19,700,000 |
Pharmacia & Upjohn Company LLC | Pfizer | pharmaceuticals | kickbacks and bribery | 2007 | USAO | $15,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | fraud | 2005 | USAO | $300,000,000 |
ICN Pharmaceuticals, Inc. | Bausch Health | pharmaceuticals | fraud | 2001 | USAO | $5,600,000 |
Roussel Uclaf S.A. | Sanofi | pharmaceuticals | drug or medical equipment safety violation | 2001 | USAO | $23,193,600 |
Allergan Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2018 | USAO | $3,500,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2021 | USAO | $75,000,000 |
Novo Nordisk Inc | Novo Holdings A/S | pharmaceuticals | False Claims Act and related | 2022 | USAO | $6,300,000 |
Abbott Laboratories Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2008 | TX-AG | $28,000,000 |
Actavis Mid-Atlantic, LLC and Actavis Elizabeth, LLC | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | TX-AG | $29,230,000 |
Boehringer Ingelheim Corp. | Boehringer Ingelheim | pharmaceuticals | False Claims Act and related | 2005 | TX-AG | $10,000,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2003 | TX-AG | $9,000,000 |
Endo Pharmaceuticals | Endo International | pharmaceuticals | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
Forest Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2013 | TX-AG | $3,000,000 |
Glenmark Generics Inc. | Glenmark Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2015 | TX-AG | $13,750,000 |
Mylan Laboratories Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | TX-AG | $23,000,000 |
Novartis Pharmaceuticals | Novartis | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | TX-AG | $6,638,250 |
Pfizer Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
Purdue Frederick Co. | Purdue Pharma | pharmaceuticals | False Claims Act and related | 2008 | TX-AG | $1,600,000 |
Ranbaxy Pharmaceuticals, Inc. et al. | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $17,875,000 |
Schering-Plough Corp. | Merck | pharmaceuticals | False Claims Act and related | 2004 | TX-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $27,000,000 |
SmithKline Beecham Corp. | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2007 | TX-AG | $1,400,000 |
Taro Pharmaceuticals USA, Inc. | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2014 | TX-AG | $8,750,000 |
Watson/Schein Pharmaceuticals Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2011 | TX-AG | $11,300,000 |
Lupin Pharmaceuticals, Inc. | Lupin Limited | pharmaceuticals | False Claims Act and related | 2019 | TX-AG | $63,000,000 |
Dr. Reddy's Laboratories | Dr. Reddy's Laboratories | pharmaceuticals | False Claims Act and related | 2022 | TX-AG | $12,900,000 |
Biovail Corporation | Bausch Health | pharmaceuticals | accounting fraud or deficiencies | 2008 | SEC | $10,000,000 |
Elan Corporation, plc | Perrigo | pharmaceuticals | accounting fraud or deficiencies | 2005 | SEC | $15,000,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | accounting fraud or deficiencies | 2004 | SEC | $150,000,000 |
Schering-Plough Corporation | Merck | pharmaceuticals | investor protection violation | 2003 | SEC | $1,000,000 |
ICN Pharmaceuticals, Inc. | Bausch Health | pharmaceuticals | accounting fraud or deficiencies | 2002 | SEC | $1,000,000 |
AstraZeneca PLC | AstraZeneca | pharmaceuticals | kickbacks and bribery | 2016 | SEC | $5,522,000 |
GlaxoSmithKline plc | GlaxoSmithKline | pharmaceuticals | kickbacks and bribery | 2016 | SEC | $20,000,000 |
Allergan Inc. | AbbVie | pharmaceuticals | investor protection violation | 2017 | SEC | $15,000,000 |
Galena Biopharma, Inc. | SELLAS Life Sciences Group | pharmaceuticals | accounting fraud or deficiencies | 2017 | SEC | $200,000 |
Alere Inc. | Abbott Laboratories | pharmaceuticals | accounting fraud or deficiencies | 2017 | SEC | $13,023,885 |
Aegerion Pharmaceuticals | Amryt Pharma | pharmaceuticals | investor protection violation | 2017 | SEC | $4,100,000 |
Cytrx Corporation | CytRx | pharmaceuticals | investor protection violation | 2017 | SEC | $75,000 |
Clovis Oncology Inc. | Clovis Oncology | pharmaceuticals | investor protection violation | 2018 | SEC | $20,000,000 |
Mylan N.V. | Viatris | pharmaceuticals | investor protection violation | 2019 | SEC | $30,000,000 |
Amyris, Inc. | Amyris | pharmaceuticals | investor protection violation | 2021 | SEC | $300,000 |
MUTUAL PHARMACEUTICAL CO INC | Sun Pharmaceuticals | pharmaceuticals | environmental violation | 2012 | PA-ENV | $8,500 |
MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2016 | PA-ENV | $6,943 |
MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2003 | PA-ENV | $8,978 |
SANOFI PASTEUR | Sanofi | pharmaceuticals | environmental violation | 2006 | PA-ENV | $28,620 |
SANOFI PASTEUR | Sanofi | pharmaceuticals | environmental violation | 2007 | PA-ENV | $6,400 |
MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2016 | PA-ENV | $14,906 |
MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2014 | PA-ENV | $12,270 |
MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2009 | PA-ENV | $15,720 |
MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2007 | PA-ENV | $12,565 |
MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2006 | PA-ENV | $5,033,000 |
MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2006 | PA-ENV | $194,000 |
MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2005 | PA-ENV | $7,950 |
MERCK SHARP & DOHME CORP | Merck | pharmaceuticals | environmental violation | 2000 | PA-ENV | $15,086 |
GLAXOSMITHKLINE LLC | GlaxoSmithKline | pharmaceuticals | environmental violation | 2016 | PA-ENV | $5,259 |
Abbott Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2008 | PA-AG | $6,950,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2010 | PA-AG | $27,600,000 |
Dey Pharmaceuticals | Viatris | pharmaceuticals | False Claims Act and related | 2011 | PA-AG | $2,000,000 |
TAP Pharmaceutical Products | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2011 | PA-AG | $5,240,797 |
DURAMED PHARMACEUTICALS, INC. | Teva Pharmaceutical Industries | pharmaceuticals | workplace safety or health violation | 2001 | OSHA | $7,000 |
TEVA PHARMACEUTICALS INC. | Teva Pharmaceutical Industries | pharmaceuticals | workplace safety or health violation | 2002 | OSHA | $15,300 |
IMPAX LABORATORIES, INC | Amneal Pharmaceuticals | pharmaceuticals | workplace safety or health violation | 2004 | OSHA | $18,000 |
ALPHARMA ANIMAL HEALTH COMPANY | Zoetis | pharmaceuticals | workplace safety or health violation | 2001 | OSHA | $18,300 |
GILEAD SCIENCES | Gilead Sciences | pharmaceuticals | workplace safety or health violation | 2000 | OSHA | $5,700 |
CHIRON CORPORATION | Novartis | pharmaceuticals | workplace safety or health violation | 2000 | OSHA | $90,140 |
PHIBRO-TECH INC. | Phibro Animal Health | pharmaceuticals | workplace safety or health violation | 2000 | OSHA | $31,600 |
TEVA SICOR | Teva Pharmaceutical Industries | pharmaceuticals | workplace safety or health violation | 2005 | OSHA | $5,000 |
PHARMAVITE CORP | Otsuka Pharmaceutical | pharmaceuticals | workplace safety or health violation | 2001 | OSHA | $18,300 |
PHARMAVITE | Otsuka Pharmaceutical | pharmaceuticals | workplace safety or health violation | 2005 | OSHA | $20,055 |
GENENTECH | Roche | pharmaceuticals | workplace safety or health violation | 2003 | OSHA | $11,240 |
ELAN PHARMACEUTICALS INC. | Perrigo | pharmaceuticals | workplace safety or health violation | 2003 | OSHA | $7,125 |